Australian artificial intelligence startup MedAI Tech recently announced that they have successfully developed a world-leading intelligent medical diagnostic system—AI-MediScan. This system utilizes deep learning algorithms to rapidly analyze medical images, achieving an accuracy rate of up to 98%.
The system has already undergone pilot testing in multiple Australian hospitals, with initial results showing that it outperforms traditional diagnostic methods in early cancer detection and cardiovascular risk assessment. Sarah Mitchell, CEO of MedAI Tech, stated:
“Our goal is to empower the healthcare industry with AI technology, reduce misdiagnoses, improve diagnostic efficiency, and provide a better medical experience for patients.”
Currently, this technology is undergoing certification by the Australian Therapeutic Goods Administration (TGA) and is expected to enter the global market within the next two years. This breakthrough innovation is set to revolutionize the medical diagnostics industry, further solidifying Australia's position as a global leader in AI-powered healthcare.